为您找到相关结果约500个

你是不是要搜索 期刊表观调控因子EZH2 的靶向抑制在MHC-I 介导的肝癌T 细胞免疫治疗� 点击跳转

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses

CD8+ T cell killing of MHC class I-deficient tumors

Platelet MHC class I mediates CD8(+) T-cell suppression during sepsis

Y cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of

Predicting T cell recognition of MHC class I restricted neoepitopes

EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma

Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+T Cell Response

Adaptive meets innate: CD8+ T cells kill MHC-I-negative tumour cells

Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers

Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell

Distinctive CD8(+) T cell and MHC class I signatures in polycythemia vera patients

Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity

Steering MHC-I restricted T cells towards the NKT developmental pathway

T cell programming by the cytomegalovirus MHC class I homologue UL18

Tracking Antigen-Specific CD8+T cells Using MHC Class I Pentamers

为您找到相关结果约500个

共500条页码: 1/34页15条/页